{'fraction_non_alphanumeric': 0.030947775628626693, 'fraction_numerical': 0.03288201160541586, 'mean_word_length': 5.395061728395062, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Quality of life and treatment outcomes

Of the estimated 317,000 men in the United States diagnosed with prostate carcinoma in 1996, 57% will have localized disease, and their 5‐year relative survival rate will be 98%. Limited information exists on patient‐reported quality of life (QOL) and the incidence and severity of treatment‐related side effects. The purpose of this study was to identify and compare patients' self‐reported QOL and treatment side effects 1‐5 years after radical prostatectomy or radiotherapy.